Tags Archives: COVID-19

Perfusfind S.L.

A global view of ECMO during the COVID-19 pandemic Duration: 60 minutes Language: English Date: June 25, 2020    

Perfusfind S.L.

ECMO in Covid-19: Experiences & Considerations Duration: 60 minutes Language: English Date: August 7th, 2020    

Perfusfind S.L.

Abstract FOR MORE THAN a year, patients around the world have dealt with the effects of coronavirus disease 2019 (COVID-19) infection, including acute respiratory distress syndrome (ARDS). Most patients with..

Perfusfind S.L.

Abstract In 2020, the attention of the medical community was stolen by the novel coronavirus pandemic. In the setting of the rapidly evolving and unpredictable deadly disease, there was little..

Perfusfind S.L.

Abstract The coronavirus disease 2019 (COVID-19) pandemic has increased the number of patients who require extracorporeal membrane oxygenation (ECMO). To manage the demand for ECMO, Japan ECMOnet for COVID-19 was..

Perfusfind S.L.

Patient with Covid 19 and bacterial endocarditis and thrombosis undergone MVR with biological valve new generation and LAA closure and clot evacuation and AF ablation with MAZE. [playlist ids="18638"]  ..

Perfusfind S.L.

Abstract New York City (NYC) was the epicenter of the COVID-19 pandemic in the US in March 2020. A dense city of only 302 square miles, it has had 33 359..

Perfusfind S.L.

Patient with severe tricuspid valve bacterial endocarditis and sepsis as well as covid 19 infection undergone off pump valve excision and valve rudimentary repair as well as RA closure choking..

Perfusfind S.L.

Abstract Background: COVID-19 has changed the world as we know it, and the United States continues to accumulate the largest number of COVID-related deaths worldwide. There exists a paucity of data..

Perfusfind S.L.

Abstract Disclaimer:  This is an updated guideline from the Extracorporeal Life Support Organization (ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with severe cardiopulmonary failure due to..

Perfusfind S.L.

The outbreak of severe acute respiratory syndrome-coronavirus-2, the cause of coronavirus disease 2019 (COVID-19) in December 2019 represented a global emergency accounting for more than 2.5 million deaths worldwide. It has..

Perfusfind S.L.

This case reports on a 40-year-old-female who was hospitalized with signs of respiratory distress due to SARS-CoV-2 infection. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/08/CoW_32_2021_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on a 17-year-old male patient with a history of fever, dyspnea, diffuse chest and abdominal pain, and generalized rash following COVID-19 molecular diagnosis. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/08/CoW_31_2021_E_web_compressed.pdf"]  

Perfusfind S.L.

To the Editor: Venovenous extracorporeal membrane oxygenation (ECMO) was considered early in the pandemic to rescue the most severe forms of coronavirus disease (COVID-19)–associated acute respiratory distress syndrome (ARDS). The..

Perfusfind S.L.

Abstract Purpose: To evaluate the daily values and trends over time of relevant clinical, ventilatory and laboratory parameters during the intensive care unit (ICU) stay and their association with outcome..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is often used in the management of COVID-19-related severe respiratory failure. We report the first case of a patient with COVID-19-related ARDS on ECMO support..

Perfusfind S.L.

Abstract COVID-19 can be associated with acute respiratory distress syndrome (ARDS) which increases the likelihood of morbidity and mortality. Ventilator-induced lung injury (VLI) is a known complication of mechanical ventilation (MV) and..

Perfusfind S.L.

O transplante de pulmão em si não é novidade. Mas o uso dele em pacientes com sequelas graves de Covid é quase experimental. Conheça casos de sucesso na reportagem em..

Perfusfind S.L.

Abstract Importance  Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized for COVID-19 have variously reported benefit, no effect, and harm. Objective  To estimate the association between administration of IL-6..

Perfusfind S.L.

This case reports on a 66-year-old female patient who presented to hospital for elective surgical treatment of a large right-sided renal pelvic stone. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_30_2021_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on a 62-year-old male who received a liver allograft for hepatocellular carcinoma and 2 months later was admitted with SARS-CoV-2 interstitial pneumonia. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_29_2021_E_web_compressed.pdf"]  

Perfusfind S.L.

This case reports on a 52-year-old male, who was admitted to the emergency room with signs of Acute Respiratory Distress Syndrome (ARDS) and decreased urine output. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_28_2021_E_web_compressed.pdf"] [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_29_2021_E_web_compressed.pdf"]..

Perfusfind S.L.

Zeraatian RMRC line in pulmonary embolectomy again for the patient with Covid 19 as well as massive PTE with bicaval cannulation and just one incision on the pulmonary trunc.  ..

Perfusfind S.L.

  [playlist ids="16943"]  Dr.Sam Zeraatian Nejad Davani, CEO of rockingham medical research ADKWA center as well as Head of IUMS transplant and cardiovascular surgery department.[gallery ids="16795"]        ..

Perfusfind S.L.

Abstract Prone position quickly imposed as a cornerstone in the management of patients with acute respiratory distress syndrome (ARDS) induced by coronavirus disease 2019 (COVID-19) [1, 2]. The response to..

Perfusfind S.L.

Abstract Delirium is an important public health problem. It is independently associated with worse clinical outcomes, including persistent cognitive impairment, increased mortality, and greater risk of institutionalization [1]. The prevalence..

Perfusfind S.L.

Abstract Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, more than 153 million cases have been confirmed, and more than 3.20 million individuals have died worldwide. The strategies..

Perfusfind S.L.

Abstract Venovenous extracorporeal membrane oxygenation (VV-ECMO) has been used as a rescue therapy for patients with refractory coronavirus disease (COVID-19)–associated severe acute respiratory distress syndrome (ARDS) with survival rates similar..

Perfusfind S.L.

Abstract In SARS-CoV-2 patients with severe acute respiratory distress syndrome (ARDS), Veno-Venous Extracorporeal Membrane Oxygenation (V-V ECMO) was shown to provide valuable treatment with reasonable survival in large multi-centre investigations...

Perfusfind S.L.

Abstract Prone position quickly imposed as a cornerstone in the management of patients with acute respiratory distress syndrome (ARDS) induced by coronavirus disease 2019 (COVID-19) [, ]. The response to prone..